BioPharmaTrend
Latest News
All Topics
  • Artificial Intelligence
  • NeuroTech
  • Premium Content
  • Knowledge Center
Interviews
Companies
  • Company Directory
  • Sponsored Case Studies
  • Create Company Profile
More
  • About Us
  • Our Team
  • Advisory Board
  • Citations and Press Coverage
  • Partner Events Calendar
  • Advertise with Us
  • Write for Us
Subscribe
Login/Join
back to Directory

OccamzRazor

OccamzRazor logo

Website
http://www.occamzrazor.com
Founded
2015
Publications
1

Technologies

AI Companies (Drug Discovery)

OccamzRazor is mapping the human Parkinsome — a dynamic knowledge map that reveals the hidden mechanisms and new treatments of Parkinson’s Disease. Only by overcoming key unsolved challenges
in data processing and natural language understanding are we able to build a complete map. We combine the map with exclusive scientific data from our research partners to navigate the intricacies of this complex disease, develop new biomarkers, new therapeutic targets, and find the fastest paths to cures.

Neuroscience NLP

#advertisement
ThermoFisher Scientific: Integrated genetic technologies for cell therapy development
#advertisement
Webinar: AI in Clinical Trials

 

R&D Platform

We combine the map with exclusive scientific data from our research partners to navigate the intricacies of this complex disease, develop new biomarkers, new therapeutic targets, and find the fastest paths to cures.

BiopharmaTrend.com

Where Tech Meets Bio
mail  Newsletter
in  LinkedIn
x  X
gnews  Google News
rss  RSS Feed

About


  • What we do
  • Citations and Press Coverage
  • Terms of Use
  • Privacy Policy
  • Disclaimer

We Offer


  • Premium Content
  • BioTech Scout
  • Interviews
  • Partner Events
  • Case Studies

Opportunities


  • Membership
  • Advertise
  • Submit Company
  • Write for Us
  • Contact Us

© BPT Analytics LTD 2025
We use cookies to personalise content and to analyse our traffic. You consent to our cookies if you continue to use our website. Read more details in our cookies policy.